Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glycaemic Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01087502
What this trial is testing

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT01204294
What this trial is testing

Comprehensive Add on Study in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 574
Large-scale testing (Phase 3)Study completedNCT01159600
What this trial is testing

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,504
Large-scale testing (Phase 3)Study completedNCT02681094
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInadequate Glycaemic Control
AstraZeneca 905
Large-scale testing (Phase 3)Study completedNCT02453555
What this trial is testing

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 275
Testing effectiveness (Phase 2)Study completedNCT00309608
What this trial is testing

Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333
Large-scale testing (Phase 3)Study completedNCT01778049
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 708
Large-scale testing (Phase 3)Study completedNCT00673231
What this trial is testing

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,240
Large-scale testing (Phase 3)Study completedNCT01128153
What this trial is testing

Saxagliptin Triple Oral Therapy

Who this might be right for
Type 2 Diabetes
AstraZeneca 257
Post-approval studies (Phase 4)Study completedNCT01006590
What this trial is testing

Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 286
Large-scale testing (Phase 3)Study completedNCT01183013
What this trial is testing

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 936
Large-scale testing (Phase 3)Study completedNCT00996658
What this trial is testing

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 278
Testing effectiveness (Phase 2)Study completedNCT02113332
What this trial is testing

Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections

Who this might be right for
Type 2 Diabetes Mellitus
Vastra Gotaland Region 124
Large-scale testing (Phase 3)Study completedNCT00698932
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
AstraZeneca 568
Large-scale testing (Phase 3)Study completedNCT01947855
What this trial is testing

Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 60
Post-approval studies (Phase 4)Study completedNCT00118963
What this trial is testing

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Steno Diabetes Center Copenhagen 102
Post-approval studies (Phase 4)UnknownNCT02462369
What this trial is testing

Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients

Who this might be right for
MicroalbuminuriaMicroalbuminuria /Creatinine Ratios ACR
The Second Hospital of Nanjing Medical University 88
Large-scale testing (Phase 3)Study completedNCT02489968
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 880
Large-scale testing (Phase 3)Study completedNCT00602472
What this trial is testing

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,058
Large-scale testing (Phase 3)Study completedNCT00660907
What this trial is testing

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,217
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation